TallyHQ
github
Client · LDA

AMGEN INC

6 filings 42 bills mentioned 1 registrants 5 quarters ~$18,450,000 reported
Client ID
103709

Bills lobbied on

Bills referenced in this client's quarterly filings, ranked by filing count.

S 1041
Affordable Prescriptions for Patients Act
CPT
6
HR 1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
HCRMMM
6
S 1040
Drug Competition Enhancement Act
CPT
6
HR 1672
Maintaining Investments in New Innovation Act
HCRMMM
6
HCONRES 14
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
HCRMMMTAX
6
HR 2214
DRUG Act
HCR
5
HR 1968
Full-Year Continuing Appropriations and Extensions Act, 2025
HCRMMM
5
S 1954
Biosimilar Red Tape Elimination Act
HCR
5
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
HCRMMMTAX
5
HR 946
ORPHAN Cures Act
HCRMMM
5
HR 1328
Supply Chain Security and Growth Act of 2025
TAX
3
HR 1574
RESTORE Patent Rights Act of 2025
CPT
3
HR 3160
PREVAIL Act
CPT
3
HR 3152
Patent Eligibility Restoration Act of 2025
CPT
3
S 708
RESTORE Patent Rights Act of 2025
CPT
3
HR 5256
340B ACCESS Act
HCR
3
S 1553
PREVAIL Act
CPT
3
S 1546
Patent Eligibility Restoration Act of 2025
CPT
3
HR 5526
Biosimilar Red Tape Elimination Act
HCR
3
HR 4581
340B PATIENTS Act of 2025
HCR
2
S 2276
ETHIC Act
CPT
2
HR 6166
Lowering Drug Costs for American Families Act
HCRMMM
2
S 3510
Biosimilar Inspection Modernization Act of 2025
HCR
2
HR 5509
Safe Step Act
HCR
2
S 2296
National Defense Authorization Act for Fiscal Year 2026
CPTHCR
2
S 3345
PBM Price Transparency and Accountability Act
HCRMMM
2
S 3349
PBM Disclosure Act
HCRMMM
2
S 3019
No Big Blockbuster Bailouts Act
HCRMMM
2
HR 3269
ETHIC Act
CPT
2
HR 4317
PBM Reform Act of 2025
HCRMMM
2
HR 6485
Skinny Labels, Big Savings Act
CPT
2
S 3452
Biological Intellectual Property Protection Act of 2025
CPTTAR
1
S 3788
CLEAR LABELS Act
HCR
1
SCONRES 7
An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
HCRMMM
1
HR 7837
Most Favored Patient Act of 2026
HCRMMM
1
HR 6703
Lower Health Care Premiums for All Americans Act
HCR
1
HR 6624
Biological Intellectual Property Protection Act of 2025
CPTTAR
1
S 2658
Medication Affordability and Patent Integrity Act
CPT
1
S 43
Skinny Labels, Big Savings Act
CPT
1
HRES 928
Affirming support for most-favored-Nation drug pricing for United States patients.
HCRMMM
1
HR 4299
Protecting Patient Access to Cancer and Complex Therapies Act
HCRMMM
1
HR 7391
Community Health Center Drug Pricing Protection Act
HCR
1

Registrants

Lobbying firms that filed on behalf of this client.

AMGEN, INC. 6

Source: Senate LDA quarterly filings (LD-2). Bill mentions extracted from free-text "specific issues" descriptions.